Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Grants to come with a COVID-19 indication

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Jul 27, 2022 2:31pm

221 Views

Post# 34854517

Grants to come with a COVID-19 indication

The Medicago story is a good reference point in that we can see how many grants it received from both levels of governments. 173M$ by the federal government for securing doses and 7M$ by the provincial government.

https://www.crunchbase.com/organization/medicago/company_financials

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing